Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Arolt

Showing results (221-230 of 351) with videos related to

Pageof 36
Sort By:
Neuroimage|May 21, 2021
Neural adaptation of cingulate and insular activity during delayed fear extinction: A replicable pattern across assessment sites and repeated measurementsIsabelle C Ridderbusch, Adrian Wroblewski, Yunbo Yang, et al.
Frontiers in Psychiatry|October 13, 2022
Expression of CXCR4 on CD4<sup>+</sup> T cells predicts body composition parameters in female adolescents with anorexia nervosaJana Freff, Lisa Bröker, Rafael Leite Dantas, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2020
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective studyJulia Brandt, Katharina Warnke, Silke Jörgens, et al.
JAMA Psychiatry|May 5, 2016
Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging DataRonny Redlich, Nils Opel, Dominik Grotegerd, et al.
Journal of Affective Disorders|September 5, 2020
Association of 5-HTTLPR/rs25531 with depressive symptoms in patients with coronary heart disease: A prospective studyKatharina Warnke, Julia Brandt, Silke Jörgens, et al.
Biological Psychiatry|August 28, 2012
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorderTilo Kircher, Volker Arolt, Andreas Jansen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 25, 2016
Stem Cell Factor (SCF) is a putative biomarker of antidepressant responseFrancesco Benedetti, Sara Poletti, Thomas A Hoogenboezem, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 21, 2020
Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patientsGara Arteaga-Henriquez, Bianka Burger, Elif Weidinger, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 15, 2017
Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment RespondersDiana Ahmetspahic, Kathrin Schwarte, Oliver Ambrée, et al.
Journal of Clinical Psychology|March 19, 2013
Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobiaSandra Cammin-Nowak, Sylvia Helbig-Lang, Thomas Lang, et al.
Pageof 36

Showing results (221-230 of 351) with videos related to

Sort By:
Pageof 36
Neuroimage|May 21, 2021
Neural adaptation of cingulate and insular activity during delayed fear extinction: A replicable pattern across assessment sites and repeated measurementsIsabelle C Ridderbusch, Adrian Wroblewski, Yunbo Yang, et al.
Frontiers in Psychiatry|October 13, 2022
Expression of CXCR4 on CD4<sup>+</sup> T cells predicts body composition parameters in female adolescents with anorexia nervosaJana Freff, Lisa Bröker, Rafael Leite Dantas, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2020
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective studyJulia Brandt, Katharina Warnke, Silke Jörgens, et al.
JAMA Psychiatry|May 5, 2016
Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging DataRonny Redlich, Nils Opel, Dominik Grotegerd, et al.
Journal of Affective Disorders|September 5, 2020
Association of 5-HTTLPR/rs25531 with depressive symptoms in patients with coronary heart disease: A prospective studyKatharina Warnke, Julia Brandt, Silke Jörgens, et al.
Biological Psychiatry|August 28, 2012
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorderTilo Kircher, Volker Arolt, Andreas Jansen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 25, 2016
Stem Cell Factor (SCF) is a putative biomarker of antidepressant responseFrancesco Benedetti, Sara Poletti, Thomas A Hoogenboezem, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 21, 2020
Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patientsGara Arteaga-Henriquez, Bianka Burger, Elif Weidinger, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 15, 2017
Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment RespondersDiana Ahmetspahic, Kathrin Schwarte, Oliver Ambrée, et al.
Journal of Clinical Psychology|March 19, 2013
Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobiaSandra Cammin-Nowak, Sylvia Helbig-Lang, Thomas Lang, et al.
Pageof 36